Head to head
Azenta vs Intuitive Surgical
Side-by-side on the measures that matter, with a plain-English read. Full detail: AZTA · ISRG
AZTA
Azenta
44.80-4.86%
1-year price shape — +49% over the period
Quant Rating C · 87/100
vs
ISRG
Intuitive Surgical
399.05-2.01%
1-year price shape — -28% over the period
Quant Rating E · 15/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical earns the most per share.
| AZTA | ISRG | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 44.80 | 399.05 |
| Change today | -4.86% | -2.01% |
| 1-year return | +49.3% | -27.7% |
| Market cap | $1.88B | $138.33B |
| 52-week range | 15.93 – 50.06 | 328.57 – 603.88 |
| Valuation | ||
| P/E (TTM) | -12.11 | 48.25 |
| P/E percentile, own 5-yr range | 56th | 16th |
| P/B | 1.34 | 8.65 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -3.70 | 7.87 |
| Net profit (TTM) | $-155.18M | $2.73B |
| Revenue (TTM) | $621.70M | $11.58B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +5.0% | +21.7% |
| Gross margin | 44.2% | 67.2% |
| Operating margin | -3.3% | 32.3% |
| Net margin | -26.9% | 25.5% |
| Free cash flow (TTM) | $27.43M | $3.60B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 123.3% | 86.7% |
| Insider activity (12mo) | 38 buy / 12 sell | 17 buy / 33 sell |
| Short interest (% of float) | 12.3% | 2.0% |
| Analyst consensus | 67% buy / 33% hold (3) | 100% buy (18) |
| Analyst price target | $53 (+18%) | $516 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | C (87) | E (15) |
| Company | ||
| Employees | 3,000 | 17,021 |
| Founded | 1978 | 1995 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.